المساعد الشخصي الرقمي

مشاهدة النسخة كاملة : UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain


ahlam1399
09-10-2015, 05:53 PM
UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain
LONDON, Sept 10 (Reuters) - Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid.


http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/1/rc.htm)

http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/2/rc.htm)

http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/rc/3/rc.htm)

http://da.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/a2.img (http://da.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/ach.img (http://adchoice.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/ach.htm)http://pi.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238385505521/u/49/f/654213/c/35217/s/49bbc55f/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49bbc55f/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=EFgsaDzGsvI:SbSL9GuUAac:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=EFgsaDzGsvI:SbSL9GuUAac:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=EFgsaDzGsvI:SbSL9GuUAac:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=EFgsaDzGsvI:SbSL9GuUAac:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=EFgsaDzGsvI:SbSL9GuUAac:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/EFgsaDzGsvI